Medicare Enrolled
Dr. John Cudecki, MD
Urology Physician · Chicago, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cudecki from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cudecki?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cudecki
Dr. John Cudecki is an urology physician in Chicago, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Cudecki performed 3,330 Medicare services across 1,295 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cudecki received a total of $30,047 from 71 pharmaceutical and/or device companies across 673 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cudecki is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 28% volume in IL
$30,047 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,330
Medicare services
Top 28% in IL for urology physician
1,295
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~166 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Leuprolide injectable, camcevi, 1 mg | 1,176 | $68 | $150 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
415 | $8 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
396 | $60 | $164 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
334 | $8 | $20 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
282 | $2 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
272 | $93 | $228 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
243 | $45 | $129 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
66 | $40 | $154 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
42 | $200 | $930 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
37 | $29 | $275 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
27 | $111 | $367 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $86 | $223 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $39 | $106 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
12 | $43 | $97 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$30,047
Total received (2018-2024)
Avg $4,292/year across 7 years
Top 8% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
673
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,874 (52.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,897 (46.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$276 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$9,990
2023
$6,982
2022
$2,612
2021
$2,291
2020
$2,876
2019
$3,375
2018
$1,922
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Bayer Healthcare Pharmaceuticals Inc.
$4,126
Janssen Biotech, Inc.
$3,538
Sumitomo Pharma America, Inc.
$513
Blue Earth Diagnostics Limited
$180
ABBVIE INC.
$177
Antares Pharma, Inc.
$165
COLOPLAST CORP
$148
Dendreon Pharmaceuticals LLC
$131
Merck Sharp & Dohme LLC
$125
Agiliti Surgical, Inc.
$111
Novartis Pharmaceuticals Corporation
$103
PFIZER INC.
$94
ACCORD HEALTHCARE, INC.
$89
Olympus America Inc.
$73
AstraZeneca Pharmaceuticals LP
$70
Teleflex LLC
$58
Astellas Pharma US Inc
$46
PROCEPT BioRobotics Corporation
$42
Myriad Genetic Laboratories, Inc.
$38
Endo USA, Inc.
$33
Tolmar, Inc.
$31
Tempus AI, Inc
$29
Medtronic, Inc.
$26
180 Medical, Inc.
$22
Avation Medical, Inc.
$21
Top 3 companies account for 81.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$9,002
Bayer Healthcare Pharmaceuticals Inc.
$4,357
AstraZeneca Pharmaceuticals LP
$2,039
PROCEPT BioRobotics Corporation
$1,800
Astellas Pharma US Inc
$1,567
Sumitomo Pharma America, Inc.
$1,025
Dendreon Pharmaceuticals LLC
$661
Axonics, Inc.
$557
Antares Pharma, Inc.
$484
TOLMAR Pharmaceuticals, Inc.
$478
Olympus America Inc.
$455
Endo Pharmaceuticals Inc.
$445
PFIZER INC.
$443
Bayer HealthCare Pharmaceuticals Inc.
$433
Boston Scientific Corporation
$391
Merck Sharp & Dohme LLC
$372
Blue Earth Diagnostics Limited
$339
ABBVIE INC.
$330
Teleflex LLC
$295
UroGPO LLC
$279
COLOPLAST CORP
$237
SRS Medical Systems, Inc.
$185
ACCORD HEALTHCARE, INC.
$184
Allergan, Inc.
$179
Merck Sharp & Dohme Corporation
$177
Novartis Pharmaceuticals Corporation
$174
Coloplast Corp
$166
AbbVie Inc.
$162
Travere Therapeutics, Inc.
$159
Myovant Sciences Inc.
$149
UROVANT SCIENCES INC
$147
AngioDynamics, Inc.
$142
Tolmar, Inc.
$138
NeoTract Inc.
$132
UROGEN PHARMA, INC.
$126
Retrophin, Inc.
$115
Medtronic, Inc.
$113
MEDIVATION FIELD SOLUTIONS LLC
$111
Agiliti Surgical, Inc.
$111
Amgen Inc.
$109
Myriad Genetic Laboratories, Inc.
$97
AbbVie, Inc.
$95
Clarus Therapeutics Inc.
$79
Ambu Inc.
$76
Clovis Oncology, Inc.
$70
Telix Pharmaceuticals
$66
180 Medical, Inc.
$63
Cardinal Health 414 LLC
$62
Accord Healthcare, Inc.
$61
BOSTON SCIENTIFIC CORPORATION
$44
GENZYME CORPORATION
$43
CARDINAL HEALTH 414 LLC
$42
Ferring Pharmaceuticals Inc.
$40
ConvaTec Inc.
$37
Foundation Medicine, Inc.
$36
Avadel Specialty Pharmaceuticals, LLC
$35
Kowa Pharmaceuticals America, Inc.
$34
Endo USA, Inc.
$33
Tempus AI, Inc
$29
Allergan Inc.
$25
Ethicon US, LLC
$24
Novo Nordisk Inc
$24
Verity Pharmaceuticals Inc.
$23
Progenics Pharmaceuticals, Inc.
$22
Avation Medical, Inc.
$21
ABC Home Medical Supply, Inc.
$21
Supernus Pharmaceuticals, Inc.
$18
Medtronic USA, Inc.
$17
Laborie Medical Technologies Corp.
$16
Aytu Bioscience, Inc
$14
CooperSurgical, Inc.
$13
Top 3 companies account for 51.2% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADVANTAGE · AMS · AQUABEAM SYSTEM · AVYCAZ · All-In-One · Altis · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · Bulkamid · CAMCEVI · CYSTO-NEPHRO VIDEOSCOPE · Coloplast TFL Drive · EDEX · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL BPH · GENERAL MALE SUI · GENERAL - BPH · GENERAL BPH · GENTLECATH · GentleCath · Gyrus ACMI · ILLUCCIX · INTERSTIM · JATENZO · JEVTANA · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · Livalo · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · Natesto · Noctiva · Non-Gyn Products · Nubeqa · ORGOVYX · Olympus Laser Devices · Otezla · Ozempic · PENILE & TESTICULAR RECONSTRUCTN · PLUVICTO · POSLUMA · PREZCOBIX · PROLARIS · PROVENGE · PYLARIFY · Prolaris · REZUM · Rezum Generator · Rubraca · SOLYX · SUTENT · Sonablate HIFU · Spanner Prothetic Stent · SpeediCath · TITAN · TLANDO · TOVIAZ · Thiola · Titan · Trelstar · UROLIFT · UroLift · UroLift System · VESICARE · Veozah · Vivally · XGEVA · XIAFLEX · XT CDX · XTANDI · XYOSTED · Xofigo · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (53%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for urology physician in IL.
Geographic Context
Urology physicians within 10 mi
315
Per 100K population
6.1
County median income
$81,797
Nearest hospital
INSIGHT HOSPITAL AND MEDICAL CENTER CHICAGO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cudecki is a clinical cardiology specialist, with above-average Medicare volume (top 28% in IL), with low-engagement industry engagement in the top 8% of IL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cudecki experienced with leuprolide injectable, camcevi, 1 mg?
Based on Medicare claims data, Dr. Cudecki performed 1,176 leuprolide injectable, camcevi, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cudecki receive payments from pharmaceutical companies?
Yes. Dr. Cudecki received a total of $30,047 from 71 companies across 673 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cudecki's costs compare to other urology physicians in Chicago?
Dr. Cudecki's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cudecki) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Chicago
Browse urology physicians in Chicago ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in IL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in IL
Which IL urology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Bayer Healthcare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer Healthcare Pharmaceuticals Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology